Suppr超能文献

胰高血糖素的变时作用依赖于钙。

Glucagon's chronotropic action is calcium dependent.

作者信息

Chernow B, Zaloga G P, Malcolm D, Willey S C, Clapper M, Holaday J W

出版信息

J Pharmacol Exp Ther. 1987 Jun;241(3):833-7.

PMID:2885409
Abstract

Evidence is increasing that many anesthetics and cardiovascular agents alter cellular Ca kinetics and flux. In prior work we demonstrated that the tachycardic effects of glucagon were significantly blunted by Ca channel blockade, but not by beta adrenergic receptor blockade. Thus, the chronotropic effects of glucagon may be dependent upon extracellular Ca levels. Based upon these observations, we tested the hypothesis that changes in circulating ionized Ca concentrations may alter glucagon's ability to increase heart rate in rats. In conscious normocalcemic rats, glucagon's tachycardic actions were dose related with peak effects obtained at 1 to 2 min and persisting approximately 10 min after 1.0 mg/kg of glucagon. The effects of altered Ca levels on glucagon tachycardia were evaluated in three groups of rats: 1) rats rendered hypercalcemic by the infusion of Ca chloride (10, 50 or 100 mg/ml/hr); 2) rats rendered hypocalcemic by infusion of the Ca chelator EDTA (15 or 30 mg/ml/hr); and 3) normocalcemic rats infused with saline. Normocalcemic rats had a mean ionized Ca level of 4.73 mg/dl. In rats, increasing Ca chloride doses resulted in increasing mean serum ionized Ca levels (5.24, 8.35 and 15.2 mg/dl, respectively), whereas increasing doses of EDTA produced progressive decreases in mean ionized Ca (3.62 and 2.13 mg/dl, respectively). Severe hypo (2.13 mg/dl)- or hypercalcemia (15.2 mg/dl) significantly blunted glucagon's chronotropic action (51 and 44%, respectively). From these data, we conclude that glucagon has its maximal tachycardic action at physiologic Ca levels (being blunted by both hyper- and hypocalcemia), indicating that this effect of glucagon is Ca dependent.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

越来越多的证据表明,许多麻醉剂和心血管药物会改变细胞钙动力学和通量。在之前的研究中,我们证明了钙通道阻滞剂可显著减弱胰高血糖素的心动过速作用,但β肾上腺素能受体阻滞剂则无此作用。因此,胰高血糖素的变时作用可能取决于细胞外钙水平。基于这些观察结果,我们检验了以下假设:循环中离子钙浓度的变化可能会改变胰高血糖素增加大鼠心率的能力。在清醒的血钙正常的大鼠中,胰高血糖素的心动过速作用与剂量相关,在注射1.0mg/kg胰高血糖素后1至2分钟达到峰值效应,并持续约10分钟。通过三组大鼠评估钙水平改变对胰高血糖素性心动过速的影响:1)通过输注氯化钙(10、50或100mg/ml/小时)使大鼠血钙过高;2)通过输注钙螯合剂乙二胺四乙酸(EDTA,15或30mg/ml/小时)使大鼠血钙过低;3)输注生理盐水的血钙正常大鼠。血钙正常的大鼠平均离子钙水平为4.73mg/dl。在大鼠中,氯化钙剂量增加导致平均血清离子钙水平升高(分别为5.24、8.35和15.2mg/dl),而EDTA剂量增加则使平均离子钙水平逐渐降低(分别为3.62和2.13mg/dl)。严重低钙(2.13mg/dl)或高钙血症(15.2mg/dl)显著减弱了胰高血糖素的变时作用(分别为51%和44%)。根据这些数据,我们得出结论,胰高血糖素在生理钙水平时具有最大的心动过速作用(高钙血症和低钙血症均使其减弱),这表明胰高血糖素的这种作用依赖于钙。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验